The most common adverse event reported was arthralgia ( stratum I : @ placebo and @ anastrozole ; stratum II : @ placebo/placebo , @ placebo/risedronate , @ anastrozole/placebo , and @ anastrozole/risedronate ; stratum III : @ placebo/risedronate , @ anastrozole/risedronate ) .